Wall Road Breakfast Podcast: Meta Snaps Up Manus
Kenneth Cheung/iStock Unreleased through Getty Photographs
Hear beneath or on the go through Apple Podcasts and Spotify
Meta to amass Singapore-based Manus for AI agent capabilities. (00:20) Boeing (BA) scores $8.6B contract to construct plane for Israel Air Pressure. (01:09) Novo Nordisk (NVO) cuts Wegovy value in China. (01:56)
That is an abridged transcript.
Meta (META) mentioned on Monday that it can purchase Manus—a Singapore-based AI startup specializing in general-purpose AI brokers—to combine superior AI into client and enterprise merchandise.
The monetary phrases of the deal weren’t disclosed. Presently primarily based in Singapore, Manus was initially based in China by Butterfly Impact Know-how earlier than relocating its headquarters.
The startup achieved a $125 million annual income run charge shortly after launching its subscription-based AI agent for duties like analysis, coding, information evaluation, resume screening, and inventory evaluation. Manus is about to proceed working from Singapore.
The acquisition aligns with Meta (META) CEO Mark Zuckerberg’s precedence on AI infrastructure, information facilities, and monetization past metaverse efforts. This marks the corporate’s fifth AI-related acquisition in 2025 and alerts the corporate’s intensifying deal with agentic AI skillset growth.
Boeing (BA) was awarded a contract for as a lot as $8.6 billion from the U.S. Air Pressure on Monday to construct F-15 fighter jets for the Israeli Air Pressure.
The contract “supplies for the design, integration, instrumentation, check, manufacturing and supply of 25 new F-15IA plane for the Israeli Air Pressure with an choice for an extra 25 F-15IA plane,” with the work to be carried out in St. Louis, Mo., and anticipated to be accomplished by year-end 2035. the Pentagon mentioned.
Individually, the U.S. Air Pressure mentioned Boeing (BA) obtained a modification to a earlier award for depot upkeep companies and provide administration in Oklahoma Metropolis, elevating the award to $4.2 billion from $1.5 billion.
Novo Nordisk (NVO) has lowered the value of its GLP-1 treatment Wegovy (semaglutide) in China, the place it’s authorized for weight discount.
Checklist costs for the 2 highest dosage strengths have been minimize by almost 50% in a number of provinces, in line with native media, Bloomberg reported.
The transfer comes as semaglutide’s patent in China will expire in March 2026, setting the stage for a flood of semaglutide generics to hit the market.
Earlier this yr, an estimate projected that 65% of the Chinese language inhabitants could possibly be thought of overweight by 2030.
What’s Trending on Looking for Alpha
SA Asks: Would SpaceX inventory be an excellent funding?
Silver slammed in greatest one-day drop since 2021, gold additionally plunges
Samsung wins annual U.S. approval for chipmaking device shipments to China – report
Dow, S&P and Nasdaq futures are within the inexperienced. Crude oil is up 0.5% at $58/barrel. Bitcoin is up 0.8% at $87,000. Gold is up 0.8% at $4,369.
The FTSE 100 is up 0.2% and the DAX is up 0.5%.
The greatest movers for the day premarket: New Period Vitality & Digital (NUAI) -4.83% – Shares slid, attributed to the fallout from a civil grievance filed by the State of New Mexico Legal professional Common and the New Mexico Oil Conservation Division.
On at this time’s financial calendar:
